Different Effects of Lifestyle Intervention in High- and Low-Risk Prediabetes

糖尿病前期 医学 血糖性 内科学 2型糖尿病 糖尿病 随机对照试验 空腹血糖受损 胰岛素 内分泌学 糖耐量受损
作者
Andreas Fritsche,Robert Wagner,Martin Heni,Kοnstantinos Kantartzis,Jürgen Machann,Fritz Schick,Rainer Lehmann,Andreas Peter,Corinna Dannecker,Louise Fritsche,Vera Valenta,Renate Schick,Peter P. Nawroth,Stefan Kopf,Andreas FH Pfeiffer,Stefan Kabisch,Ulrike Dambeck,Michael Stümvoll,Matthias Blüher,Andreas L. Birkenfeld
标识
DOI:10.2337/figshare.16613905
摘要

Lifestyle intervention (LI) can prevent type 2 diabetes, but response to LI varies depending on risk subphenotypes. We tested if prediabetic individuals with low risk benefit from conventional LI and individuals with high risk benefit from an intensification of LI in a multi-center randomized controlled intervention over 12 months with 2 years follow up. 1105 prediabetic individuals based on ADA glucose criteria were stratified into a high- and low-risk phenotype, based on previously described thresholds of insulin secretion, insulin sensitivity and liver fat content. Low-risk individuals were randomly assigned to conventional LI according to the DPP protocol or control (1:1), high-risk individuals to conventional or intensified LI with doubling of required exercise (1:1). A total of 908 (82%) participants completed the study. In high-risk individuals, the difference between conventional and intensified LI in post-challenge glucose change was -0.29 mmol/l [CI:-0.54;-0.04], p=0.025. Liver fat (-1.34 percentage points [CI:-2.17;-0.50], p=0.002) and cardiovascular risk (-1.82[CI:-3.13-0.50],p=0.007) underwent larger reductions with intensified than with conventional LI. During a follow up of 3 years, intensified compared to conventional LI had a higher probability to normalize glucose tolerance (p=0.008). In conclusion, it is possible in high-risk individuals with prediabetes to improve glycemic and cardiometabolic outcomes by intensification of LI. Individualized, risk-phenotype-based LI may be beneficial for the prevention of diabetes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
刚刚
研友_LX2vJZ发布了新的文献求助30
1秒前
LJH完成签到,获得积分10
1秒前
华CC完成签到,获得积分20
1秒前
舒适向薇完成签到 ,获得积分10
1秒前
小龙发布了新的文献求助10
2秒前
任性子骞完成签到,获得积分10
2秒前
2秒前
2秒前
星河入梦来完成签到,获得积分10
2秒前
shelemi发布了新的文献求助10
3秒前
Mint发布了新的文献求助10
4秒前
4秒前
kakakakak完成签到,获得积分10
6秒前
这杯酒名忘情完成签到,获得积分10
6秒前
6秒前
7秒前
7秒前
7秒前
8秒前
8秒前
8秒前
8秒前
怕孤单的大神完成签到,获得积分10
8秒前
共享精神应助StarXG采纳,获得10
8秒前
77完成签到,获得积分10
9秒前
收容成功完成签到,获得积分10
9秒前
9秒前
Yolo发布了新的文献求助10
9秒前
橙子完成签到,获得积分10
10秒前
清儿完成签到,获得积分10
10秒前
天天快乐应助小烟花采纳,获得10
10秒前
小成完成签到,获得积分10
10秒前
李三金嘻嘻完成签到,获得积分10
11秒前
唐妹妹完成签到 ,获得积分10
11秒前
ASLYJS应助珂颜堂AI采纳,获得10
11秒前
毫无意义完成签到,获得积分10
11秒前
zwd完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6953073
求助须知:如何正确求助?哪些是违规求助? 8637024
关于积分的说明 18315184
捐赠科研通 6396547
什么是DOI,文献DOI怎么找? 3082634
关于科研通互助平台的介绍 2128415
邀请新用户注册赠送积分活动 2059568